Global Passive Transdermal Drug Delivery Market Research Report 2020

1.1 Product Overview and Scope of Passive Transdermal Drug Delivery

1.2 Passive Transdermal Drug Delivery Segment by Type

1.2.1 Global Passive Transdermal Drug Delivery Production Growth Rate Comparison by Type 2020 VS 2026

1.2.2 Microfluidics

1.2.3 Smart Pill Technology (SPT)

1.3 Passive Transdermal Drug Delivery Segment by Application

1.3.1 Passive Transdermal Drug Delivery Consumption Comparison by Application: 2020 VS 2026

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Passive Transdermal Drug Delivery Market by Region

1.4.1 Global Passive Transdermal Drug Delivery Market Size Estimates and Forecasts by Region: 2020 VS 2026

1.4.2 North America Estimates and Forecasts (2015-2026)

1.4.3 Europe Estimates and Forecasts (2015-2026)

1.4.4 China Estimates and Forecasts (2015-2026)

1.4.5 Japan Estimates and Forecasts (2015-2026)

1.5 Global Passive Transdermal Drug Delivery Growth Prospects

1.5.1 Global Passive Transdermal Drug Delivery Revenue Estimates and Forecasts (2015-2026)

1.5.2 Global Passive Transdermal Drug Delivery Production Capacity Estimates and Forecasts (2015-2026)

1.5.3 Global Passive Transdermal Drug Delivery Production Estimates and Forecasts (2015-2026)

1.6 Passive Transdermal Drug Delivery Industry

1.7 Passive Transdermal Drug Delivery Market Trends

2 Market Competition by Manufacturers

2.1 Global Passive Transdermal Drug Delivery Production Capacity Market Share by Manufacturers (2015-2020)

2.2 Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2015-2020)

2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.4 Global Passive Transdermal Drug Delivery Average Price by Manufacturers (2015-2020)

2.5 Manufacturers Passive Transdermal Drug Delivery Production Sites, Area Served, Product Types

2.6 Passive Transdermal Drug Delivery Market Competitive Situation and Trends

2.6.1 Passive Transdermal Drug Delivery Market Concentration Rate

2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue

2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

3.1 Global Production Capacity of Passive Transdermal Drug Delivery Market Share by Regions (2015-2020)

3.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Regions (2015-2020)

3.3 Global Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.4 North America Passive Transdermal Drug Delivery Production

3.4.1 North America Passive Transdermal Drug Delivery Production Growth Rate (2015-2020)

3.4.2 North America Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.5 Europe Passive Transdermal Drug Delivery Production

3.5.1 Europe Passive Transdermal Drug Delivery Production Growth Rate (2015-2020)

3.5.2 Europe Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.6 China Passive Transdermal Drug Delivery Production

3.6.1 China Passive Transdermal Drug Delivery Production Growth Rate (2015-2020)

3.6.2 China Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.7 Japan Passive Transdermal Drug Delivery Production

3.7.1 Japan Passive Transdermal Drug Delivery Production Growth Rate (2015-2020)

3.7.2 Japan Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Passive Transdermal Drug Delivery Consumption by Regions

4.1 Global Passive Transdermal Drug Delivery Consumption by Regions

4.1.1 Global Passive Transdermal Drug Delivery Consumption by Region

4.1.2 Global Passive Transdermal Drug Delivery Consumption Market Share by Region

4.2 North America

4.2.1 North America Passive Transdermal Drug Delivery Consumption by Countries

4.2.2 U.S.

4.2.3 Canada

4.3 Europe

4.3.1 Europe Passive Transdermal Drug Delivery Consumption by Countries

4.3.2 Germany

4.3.3 France

4.3.4 U.K.

4.3.5 Italy

4.3.6 Russia

4.4 Asia Pacific

4.4.1 Asia Pacific Passive Transdermal Drug Delivery Consumption by Region

4.4.2 China

4.4.3 Japan

4.4.4 South Korea

4.4.5 Taiwan

4.4.6 Southeast Asia

4.4.7 India

4.4.8 Australia

4.5 Latin America

4.5.1 Latin America Passive Transdermal Drug Delivery Consumption by Countries

4.5.2 Mexico

4.5.3 Brazil

5 Passive Transdermal Drug Delivery Production, Revenue, Price Trend by Type

5.1 Global Passive Transdermal Drug Delivery Production Market Share by Type (2015-2020)

5.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2015-2020)

5.3 Global Passive Transdermal Drug Delivery Price by Type (2015-2020)

5.4 Global Passive Transdermal Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Passive Transdermal Drug Delivery Market Analysis by Application

6.1 Global Passive Transdermal Drug Delivery Consumption Market Share by Application (2015-2020)

6.2 Global Passive Transdermal Drug Delivery Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Passive Transdermal Drug Delivery Business

7.1 3M

7.1.1 3M Passive Transdermal Drug Delivery Production Sites and Area Served

7.1.2 3M Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.1.3 3M Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.1.4 3M Main Business and Markets Served

7.2 Actavis, Inc.

7.2.1 Actavis, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

7.2.2 Actavis, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.2.4 Actavis, Inc. Main Business and Markets Served

7.3 Bayer AG

7.3.1 Bayer AG Passive Transdermal Drug Delivery Production Sites and Area Served

7.3.2 Bayer AG Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.3.3 Bayer AG Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.3.4 Bayer AG Main Business and Markets Served

7.4 Boehringer Ingelheim GmbH

7.4.1 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Production Sites and Area Served

7.4.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.4.4 Boehringer Ingelheim GmbH Main Business and Markets Served

7.5 Corium International, Inc.

7.5.1 Corium International, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

7.5.2 Corium International, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.5.4 Corium International, Inc. Main Business and Markets Served

7.6 Echo Therapeutics, Inc.

7.6.1 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

7.6.2 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.6.4 Echo Therapeutics, Inc. Main Business and Markets Served

7.7 GlaxoSmithKline plc

7.7.1 GlaxoSmithKline plc Passive Transdermal Drug Delivery Production Sites and Area Served

7.7.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.7.4 GlaxoSmithKline plc Main Business and Markets Served

7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)

7.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Production Sites and Area Served

7.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business and Markets Served

7.9 Mylan N.V.

7.9.1 Mylan N.V. Passive Transdermal Drug Delivery Production Sites and Area Served

7.9.2 Mylan N.V. Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.9.4 Mylan N.V. Main Business and Markets Served

7.10 Novartis AG

7.10.1 Novartis AG Passive Transdermal Drug Delivery Production Sites and Area Served

7.10.2 Novartis AG Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.10.3 Novartis AG Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.10.4 Novartis AG Main Business and Markets Served

7.11 Noven Pharmaceuticals, Inc.

7.11.1 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

7.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.11.4 Noven Pharmaceuticals, Inc. Main Business and Markets Served

7.12 Transdermal Corp.

7.12.1 Transdermal Corp. Passive Transdermal Drug Delivery Production Sites and Area Served

7.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Product Introduction, Application and Specification

7.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.12.4 Transdermal Corp. Main Business and Markets Served

8 Passive Transdermal Drug Delivery Manufacturing Cost Analysis

8.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Raw Materials Price Trend

8.1.3 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery

8.4 Passive Transdermal Drug Delivery Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Passive Transdermal Drug Delivery Distributors List

9.3 Passive Transdermal Drug Delivery Customers

10 Market Dynamics

10.1 Market Trends

10.2 Opportunities and Drivers

10.3 Challenges

10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast

11.1 Global Forecasted Production of Passive Transdermal Drug Delivery (2021-2026)

11.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery (2021-2026)

11.3 Global Forecasted Price of Passive Transdermal Drug Delivery (2021-2026)

11.4 Global Passive Transdermal Drug Delivery Production Forecast by Regions (2021-2026)

11.4.1 North America Passive Transdermal Drug Delivery Production, Revenue Forecast (2021-2026)

11.4.2 Europe Passive Transdermal Drug Delivery Production, Revenue Forecast (2021-2026)

11.4.3 China Passive Transdermal Drug Delivery Production, Revenue Forecast (2021-2026)

11.4.4 Japan Passive Transdermal Drug Delivery Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast

12.1 Global Forecasted and Consumption Demand Analysis of Passive Transdermal Drug Delivery

12.2 North America Forecasted Consumption of Passive Transdermal Drug Delivery by Country

12.3 Europe Market Forecasted Consumption of Passive Transdermal Drug Delivery by Country

12.4 Asia Pacific Market Forecasted Consumption of Passive Transdermal Drug Delivery by Regions

12.5 Latin America Forecasted Consumption of Passive Transdermal Drug Delivery

13 Forecast by Type and by Application (2021-2026)

13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)

13.1.1 Global Forecasted Production of Passive Transdermal Drug Delivery by Type (2021-2026)

13.1.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Type (2021-2026)

13.1.2 Global Forecasted Price of Passive Transdermal Drug Delivery by Type (2021-2026)

13.2 Global Forecasted Consumption of Passive Transdermal Drug Delivery by Application (2021-2026)

14 Research Finding and Conclusion

15 Methodology and Data Source

15.1 Methodology/Research Approach

15.1.1 Research Programs/Design

15.1.2 Market Size Estimation

15.1.3 Market Breakdown and Data Triangulation

15.2 Data Source

15.2.1 Secondary Sources

15.2.2 Primary Sources

15.3 Author List

15.4 Disclaimer

Table 1. Global Passive Transdermal Drug Delivery Production (K Units) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Passive Transdermal Drug Delivery Market Size by Type (K Units) (US$ Million) (2020 VS 2026)

Table 3. Global Passive Transdermal Drug Delivery Consumption (K Units) Comparison by Application: 2020 VS 2026

Table 4. Global Passive Transdermal Drug Delivery Production (K Units) by Manufacturers

Table 5. Global Passive Transdermal Drug Delivery Production (K Units) by Manufacturers (2015-2020)

Table 6. Global Passive Transdermal Drug Delivery Production Share by Manufacturers (2015-2020)

Table 7. Global Passive Transdermal Drug Delivery Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2015-2020)

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Passive Transdermal Drug Delivery as of 2019)

Table 10. Global Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2015-2020)

Table 11. Manufacturers Passive Transdermal Drug Delivery Production Sites and Area Served

Table 12. Manufacturers Passive Transdermal Drug Delivery Product Types

Table 13. Global Passive Transdermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Passive Transdermal Drug Delivery Capacity (K Units) by Region (2015-2020)

Table 16. Global Passive Transdermal Drug Delivery Production (K Units) by Region (2015-2020)

Table 17. Global Passive Transdermal Drug Delivery Revenue (Million US$) by Region (2015-2020)

Table 18. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2015-2020)

Table 19. Global Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 20. North America Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 21. Europe Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 22. China Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 23. Japan Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 24. Global Passive Transdermal Drug Delivery Consumption (K Units) Market by Region (2015-2020)

Table 25. Global Passive Transdermal Drug Delivery Consumption Market Share by Region (2015-2020)

Table 26. North America Passive Transdermal Drug Delivery Consumption by Countries (2015-2020) (K Units)

Table 27. Europe Passive Transdermal Drug Delivery Consumption by Countries (2015-2020) (K Units)

Table 28. Asia Pacific Passive Transdermal Drug Delivery Consumption by Countries (2015-2020) (K Units)

Table 29. Latin America Passive Transdermal Drug Delivery Consumption by Countries (2015-2020) (K Units)

Table 30. Global Passive Transdermal Drug Delivery Production (K Units) by Type (2015-2020)

Table 31. Global Passive Transdermal Drug Delivery Production Share by Type (2015-2020)

Table 32. Global Passive Transdermal Drug Delivery Revenue (Million US$) by Type (2015-2020)

Table 33. Global Passive Transdermal Drug Delivery Revenue Share by Type (2015-2020)

Table 34. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2015-2020)

Table 35. Global Passive Transdermal Drug Delivery Consumption (K Units) by Application (2015-2020)

Table 36. Global Passive Transdermal Drug Delivery Consumption Market Share by Application (2015-2020)

Table 37. Global Passive Transdermal Drug Delivery Consumption Growth Rate by Application (2015-2020)

Table 38. 3M Passive Transdermal Drug Delivery Production Sites and Area Served

Table 39. 3M Production Sites and Area Served

Table 40. 3M Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 41. 3M Main Business and Markets Served

Table 42. Actavis, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

Table 43. Actavis, Inc. Production Sites and Area Served

Table 44. Actavis, Inc. Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 45. Actavis, Inc. Main Business and Markets Served

Table 46. Bayer AG Passive Transdermal Drug Delivery Production Sites and Area Served

Table 47. Bayer AG Production Sites and Area Served

Table 48. Bayer AG Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 49. Bayer AG Main Business and Markets Served

Table 50. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Production Sites and Area Served

Table 51. Boehringer Ingelheim GmbH Production Sites and Area Served

Table 52. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 53. Boehringer Ingelheim GmbH Main Business and Markets Served

Table 54. Corium International, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

Table 55. Corium International, Inc. Production Sites and Area Served

Table 56. Corium International, Inc. Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 57. Corium International, Inc. Main Business and Markets Served

Table 58. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

Table 59. Echo Therapeutics, Inc. Production Sites and Area Served

Table 60. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 61. Echo Therapeutics, Inc. Main Business and Markets Served

Table 62. GlaxoSmithKline plc Passive Transdermal Drug Delivery Production Sites and Area Served

Table 63. GlaxoSmithKline plc Production Sites and Area Served

Table 64. GlaxoSmithKline plc Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 65. GlaxoSmithKline plc Main Business and Markets Served

Table 66. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Production Sites and Area Served

Table 67. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Production Sites and Area Served

Table 68. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 69. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business and Markets Served

Table 70. Mylan N.V. Passive Transdermal Drug Delivery Production Sites and Area Served

Table 71. Mylan N.V. Production Sites and Area Served

Table 72. Mylan N.V. Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 73. Mylan N.V. Main Business and Markets Served

Table 74. Novartis AG Passive Transdermal Drug Delivery Production Sites and Area Served

Table 75. Novartis AG Production Sites and Area Served

Table 76. Novartis AG Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 77. Novartis AG Main Business and Markets Served

Table 78. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Production Sites and Area Served

Table 79. Noven Pharmaceuticals, Inc. Production Sites and Area Served

Table 80. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 81. Noven Pharmaceuticals, Inc. Main Business and Markets Served

Table 82. Transdermal Corp. Passive Transdermal Drug Delivery Production Sites and Area Served

Table 83. Transdermal Corp. Production Sites and Area Served

Table 84. Transdermal Corp. Passive Transdermal Drug Delivery Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 85. Transdermal Corp. Main Business and Markets Served

Table 86. Production Base and Market Concentration Rate of Raw Material

Table 87. Key Suppliers of Raw Materials

Table 88. Passive Transdermal Drug Delivery Distributors List

Table 89. Passive Transdermal Drug Delivery Customers List

Table 90. Market Key Trends

Table 91. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 92. Key Challenges

Table 93. Global Passive Transdermal Drug Delivery Production (K Units) Forecast by Region (2021-2026)

Table 94. North America Passive Transdermal Drug Delivery Consumption Forecast 2021-2026 (K Units) by Country

Table 95. Europe Passive Transdermal Drug Delivery Consumption Forecast 2021-2026 (K Units) by Country

Table 96. Asia Pacific Passive Transdermal Drug Delivery Consumption Forecast 2021-2026 (K Units) by Regions

Table 97. Latin America Passive Transdermal Drug Delivery Consumption Forecast 2021-2026 (K Units) by Country

Table 98. Global Passive Transdermal Drug Delivery Consumption (K Units) Forecast by Regions (2021-2026)

Table 99. Global Passive Transdermal Drug Delivery Production (K Units) Forecast by Type (2021-2026)

Table 100. Global Passive Transdermal Drug Delivery Revenue (Million US$) Forecast by Type (2021-2026)

Table 101. Global Passive Transdermal Drug Delivery Price (USD/Unit) Forecast by Type (2021-2026)

Table 102. Global Passive Transdermal Drug Delivery Consumption (K Units) Forecast by Application (2021-2026)

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Passive Transdermal Drug Delivery

Figure 2. Global Passive Transdermal Drug Delivery Production Market Share by Type: 2020 VS 2026

Figure 3. Microfluidics Product Picture

Figure 4. Smart Pill Technology (SPT) Product Picture

Figure 5. Global Passive Transdermal Drug Delivery Consumption Market Share by Application: 2020 VS 2026

Figure 6. Clinic

Figure 7. Hospital

Figure 8. Others

Figure 9. North America Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)

Figure 10. Europe Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)

Figure 11. China Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)

Figure 12. Japan Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate (2015-2026)

Figure 13. Global Passive Transdermal Drug Delivery Revenue (Million US$) (2015-2026)

Figure 14. Global Passive Transdermal Drug Delivery Production Capacity (K Units) (2015-2026)

Figure 15. Passive Transdermal Drug Delivery Production Share by Manufacturers in 2019

Figure 16. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers in 2019

Figure 17. Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 18. Global Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers in 2019

Figure 19. The Global 5 and 10 Largest Players: Market Share by Passive Transdermal Drug Delivery Revenue in 2019

Figure 20. Global Passive Transdermal Drug Delivery Production Market Share by Region (2015-2020)

Figure 21. Global Passive Transdermal Drug Delivery Production Market Share by Region in 2019

Figure 22. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2015-2020)

Figure 23. Global Passive Transdermal Drug Delivery Revenue Market Share by Region in 2019

Figure 24. Global Passive Transdermal Drug Delivery Production (K Units) Growth Rate (2015-2020)

Figure 25. North America Passive Transdermal Drug Delivery Production (K Units) Growth Rate (2015-2020)

Figure 26. Europe Passive Transdermal Drug Delivery Production (K Units) Growth Rate (2015-2020)

Figure 27. China Passive Transdermal Drug Delivery Production (K Units) Growth Rate (2015-2020)

Figure 28. Japan Passive Transdermal Drug Delivery Production (K Units) Growth Rate (2015-2020)

Figure 29. Global Passive Transdermal Drug Delivery Consumption Market Share by Region (2015-2020)

Figure 30. Global Passive Transdermal Drug Delivery Consumption Market Share by Region in 2019

Figure 31. North America Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 32. North America Passive Transdermal Drug Delivery Consumption Market Share by Countries in 2019

Figure 33. Canada Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 34. U.S. Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 35. Europe Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 36. Europe Passive Transdermal Drug Delivery Consumption Market Share by Countries in 2019

Figure 37. Germany America Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 38. France Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 39. U.K. Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 40. Italy Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 41. Russia Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 42. Asia Pacific Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 43. Asia Pacific Passive Transdermal Drug Delivery Consumption Market Share by Regions in 2019

Figure 44. China Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 45. Japan Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 46. South Korea Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 47. Taiwan Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 48. Southeast Asia Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 49. India Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 50. Australia Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 51. Latin America Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 52. Latin America Passive Transdermal Drug Delivery Consumption Market Share by Countries in 2019

Figure 53. Mexico Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 54. Brazil Passive Transdermal Drug Delivery Consumption Growth Rate (2015-2020) (K Units)

Figure 55. Production Market Share of Passive Transdermal Drug Delivery by Type (2015-2020)

Figure 56. Production Market Share of Passive Transdermal Drug Delivery by Type in 2019

Figure 57. Revenue Share of Passive Transdermal Drug Delivery by Type (2015-2020)

Figure 58. Revenue Market Share of Passive Transdermal Drug Delivery by Type in 2019

Figure 59. Global Passive Transdermal Drug Delivery Production Growth by Type (2015-2020) (K Units)

Figure 60. Global Passive Transdermal Drug Delivery Consumption Market Share by Application (2015-2020)

Figure 61. Global Passive Transdermal Drug Delivery Consumption Market Share by Application in 2019

Figure 62. Global Passive Transdermal Drug Delivery Consumption Growth Rate by Application (2015-2020)

Figure 63. Price Trend of Key Raw Materials

Figure 64. Manufacturing Cost Structure of Passive Transdermal Drug Delivery

Figure 65. Manufacturing Process Analysis of Passive Transdermal Drug Delivery

Figure 66. Passive Transdermal Drug Delivery Industrial Chain Analysis

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

Figure 69. Porter's Five Forces Analysis

Figure 70. Global Passive Transdermal Drug Delivery Production Capacity (K Units) and Growth Rate Forecast (2021-2026)

Figure 71. Global Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 72. Global Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 73. Global Passive Transdermal Drug Delivery Price and Trend Forecast (2021-2026)

Figure 74. Global Passive Transdermal Drug Delivery Production Market Share Forecast by Region (2021-2026)

Figure 75. North America Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 76. North America Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 77. Europe Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 78. Europe Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 79. China Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 80. China Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 81. Japan Passive Transdermal Drug Delivery Production (K Units) and Growth Rate Forecast (2021-2026)

Figure 82. Japan Passive Transdermal Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 83. Global Forecasted and Consumption Demand Analysis of Passive Transdermal Drug Delivery

Figure 84. North America Passive Transdermal Drug Delivery Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 85. Europe Passive Transdermal Drug Delivery Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 86. Asia Pacific Passive Transdermal Drug Delivery Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 87. Latin America Passive Transdermal Drug Delivery Consumption (K Units) Growth Rate Forecast (2021-2026)

Figure 88. Global Passive Transdermal Drug Delivery Production (K Units) Forecast by Type (2021-2026)

Figure 89. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Type (2021-2026)

Figure 90. Global Passive Transdermal Drug Delivery Consumption Forecast by Application (2021-2026)

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation